1. Ferron, Marine, Merlet, Nolwenn, Mihalache-Avram, Teodora, Rhéaume, Eric, Tardif, Jean-Claude. 2023. Adcy9 Gene Inactivation Improves Cardiac Function After Myocardial Infarction in Mice. In The Canadian journal of cardiology, 39, 952-962. doi:10.1016/j.cjca.2023.04.005. https://pubmed.ncbi.nlm.nih.gov/37054880/
2. Tang, Yijie, Wang, Tianyi, Zhang, Anping, Zhou, You-Lang, Shi, Jiahai. 2023. ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma. In Journal of thoracic disease, 15, 1018-1035. doi:10.21037/jtd-22-1027. https://pubmed.ncbi.nlm.nih.gov/37065546/
3. Zhang, Gang, Xi, Min, Li, Yuqian, Yang, Zhangkai, Shi, Hangyu. 2020. The ADCY9 genetic variants are associated with glioma susceptibility and patient prognosis. In Genomics, 113, 706-716. doi:10.1016/j.ygeno.2020.12.019. https://pubmed.ncbi.nlm.nih.gov/33326832/
4. Hopewell, Jemma C, Ibrahim, Maysson, Hill, Michael, Sabatine, Marc S, Collins, Rory. 2019. Impact of ADCY9 Genotype on Response to Anacetrapib. In Circulation, 140, 891-898. doi:10.1161/CIRCULATIONAHA.119.041546. https://pubmed.ncbi.nlm.nih.gov/31331193/
5. Rautureau, Yohann, Deschambault, Vanessa, Higgins, Marie-Ève, Rhéaume, Éric, Tardif, Jean-Claude. . ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein). In Circulation, 138, 1677-1692. doi:10.1161/CIRCULATIONAHA.117.031134. https://pubmed.ncbi.nlm.nih.gov/29674325/
6. Li, Haiyue, Liu, Yuanwei, Liu, Jianfeng, Li, Bin, Jin, Tianbo. 2021. Assessment of ADCY9 polymorphisms and colorectal cancer risk in the Chinese Han population. In The journal of gene medicine, 23, e3298. doi:10.1002/jgm.3298. https://pubmed.ncbi.nlm.nih.gov/33232543/
7. Lee, Nari, Yoon, Ha-Young, Park, Jin-Young, Yee, Jeong, Gwak, Hye-Sun. 2021. Association between ADCY9 Gene Polymorphisms and Ritodrine Treatment Outcomes in Patients with Preterm Labor. In Pharmaceutics, 13, . doi:10.3390/pharmaceutics13101653. https://pubmed.ncbi.nlm.nih.gov/34683946/
智鼠故事 
